Although no “universal marker” emerged, several miRNAs such as miR-21, 155, 223, and 34a were identified as both more frequently reported and mechanistically linked to critical pathways in pancreatic cancer, including KRAS, NF-kB, and PI3K/AKT. This evidence concerns the gene KRAS and familial pancreatic carcinoma.